A phase I study of CC-90002, a monoclonal antibody targeting CD47, in patients with relapsed and/or refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS): Final results Meeting Abstract
| Authors: | Zeidan, A. M.; DeAngelo, D. J.; Palmer, J. M.; Seet, C. S.; Tallman, M. S.; Wei, X.; Li, Y. F.; Hock, N.; Burgess, M. R.; Hege, K.; Stock, W. |
| Abstract Title: | A phase I study of CC-90002, a monoclonal antibody targeting CD47, in patients with relapsed and/or refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS): Final results |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160401136 |
| DOI: | 10.1182/blood-2019-125363 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1320 -- Source: Wos |
